Adjuvant everolimus after renal cell carcinoma nephrectomy - Authors' reply
Lancet
.
2024 Nov 9;404(10465):1810.
doi: 10.1016/S0140-6736(24)01768-9.
Authors
Christopher W Ryan
1
,
Catherine M Tangen
2
,
Primo N Lara Jr
3
Affiliations
1
Oregon Health and Science University Knight Cancer Institute, Portland, OR 97239, USA. Electronic address: ryanc@ohsu.edu.
2
SWOG Statistics and Data Management Center, Seattle, WA, USA.
3
University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
PMID:
39521508
DOI:
10.1016/S0140-6736(24)01768-9
No abstract available
Publication types
Letter